Related references
Note: Only part of the references are listed.Diabetes-induced vascular dysfunction involves arginase I
Maritza J. Romero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling
Sungwoo Ryoo et al.
ATHEROSCLEROSIS (2011)
Arginase-2 Mediates Diabetic Renal Injury
Sidney M. Morris et al.
DIABETES (2011)
Requirement of argininosuccinate lyase for systemic nitric oxide production
Ayelet Erez et al.
NATURE MEDICINE (2011)
Arginase 2 Deletion Reduces Neuro-Glial Injury and Improves Retinal Function in a Model of Retinopathy of Prematurity
Subhadra P. Narayanan et al.
PLOS ONE (2011)
Endothelial arginase II and atherosclerosis
Sungwoo Ryoo et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2011)
Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation
Jin Qian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries
N. N. Huynh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Arginase and vascular aging
Lakshmi Santhanam et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
Insulin reduces plasma arginase activity in type 2 diabetic patients
Sangeeta R. Kashyap et al.
DIABETES CARE (2008)
L-Arginine transporters in cardiovascular disease: A novel therapeutic target
J. P. F. Chin-Dusting et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Arginase: A critical regulator of nitric oxide synthesis and vascular function
William Durante et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
L-arginine supplementation in peripheral arterial disease - No benefit and possible harm
Andrew M. Wilson et al.
CIRCULATION (2007)
Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells
Jean-Luc Gokce Topal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells
Q Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Differences in eNOS activity because of subcellular localization are dictated by phosphorylation state rather than the local calcium environment
JE Church et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Increased arginase activity in cystic fibrosis airways
H Grasemann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Intracellular location regulates calcium-calmodulin-dependent activation of organelle-restricted eNOS
D Jagnandan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease
CR Morris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension
FK Johnson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport
CY Li et al.
BIOCHEMICAL JOURNAL (2005)
Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries
RY Loyaga-Rendon et al.
ATHEROSCLEROSIS (2005)
Endothelial function - Cardiac events
A Lerman et al.
CIRCULATION (2005)
Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles
CH Zhang et al.
HYPERTENSION (2004)
Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release
D Fulton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structural elements contribute to the calcium/calmodulin dependence on enzyme activation in human endothelial nitric-oxide synthase
PF Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression and activity of arginase isoenzymes during normal and diabetes-impaired skin repair
H Kämpfer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells
A Simon et al.
CIRCULATION RESEARCH (2003)
Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels
DE Berkowitz et al.
CIRCULATION (2003)
Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion
RS Scotland et al.
CIRCULATION RESEARCH (2002)
Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme
D Fulton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
α-lipoic acid inhibits TNF-α-induced NF-κB activation and adhesion molecule expression in human aortic endothelial cells
WJ Zhang et al.
FASEB JOURNAL (2001)
Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase
BR Flam et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2001)
Cellular regulation of endothelial nitric oxide synthase
R Govers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2001)
Increased arginase activity in aorta of mineralocorticoid-salt hypertensive rats
S Rodriguez et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2000)